Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
Clinical trial NCT05891236 · COMPLETED
Trial details
- NCT number
- NCT05891236
- Sponsor
- Gates Medical Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2024-12-13
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.